Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease

the TEMPO 4:4 Trial

TEMPO 4:4 Trial Investigators

Research output: Contribution to journalArticle

18 Citations (Scopus)

Fingerprint

Autosomal Dominant Polycystic Kidney
Safety
TEMPO
tolvaptan

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

@article{9a9af857687849d99e3450ff4ed3df04,
title = "Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial",
author = "{TEMPO 4:4 Trial Investigators} and Vicente Torres and Chapman, {Arlene B.} and Olivier Devuyst and Gansevoort, {Ron T.} and Perrone, {Ronald D.} and Ann Dandurand and John Ouyang and Czerwiec, {Frank S.} and Blais, {Jaime D.}",
year = "2017",
month = "7",
day = "1",
doi = "10.1093/ndt/gfx079",
language = "English (US)",
volume = "32",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease

T2 - the TEMPO 4:4 Trial

AU - TEMPO 4:4 Trial Investigators

AU - Torres, Vicente

AU - Chapman, Arlene B.

AU - Devuyst, Olivier

AU - Gansevoort, Ron T.

AU - Perrone, Ronald D.

AU - Dandurand, Ann

AU - Ouyang, John

AU - Czerwiec, Frank S.

AU - Blais, Jaime D.

PY - 2017/7/1

Y1 - 2017/7/1

UR - http://www.scopus.com/inward/record.url?scp=85045467910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045467910&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfx079

DO - 10.1093/ndt/gfx079

M3 - Article

VL - 32

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 7

ER -